Santen Pharmaceutical Co., Ltd. total revenue, net income and dynamics of changes in US dollar today
Santen Pharmaceutical Co., Ltd. revenue for the past few reporting periods. Net revenue Santen Pharmaceutical Co., Ltd. is now 67 819 000 000 $. Information about net revenue is taken from open sources. These are the main financial indicators of Santen Pharmaceutical Co., Ltd.. Chart of online financial report of Santen Pharmaceutical Co., Ltd.. The value of "net income" Santen Pharmaceutical Co., Ltd. on the graph is displayed in blue. Santen Pharmaceutical Co., Ltd. total revenue on the graph is shown in yellow.
Report date
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and
Change (%)
Comparing current quartal report this year to quartal report last year.
Dates of Santen Pharmaceutical Co., Ltd. finance reports: 30/06/2018, 31/12/2020, 31/03/2021. Dates and dates of financial statements are established by the laws of the country where the company operates. The latest date of the financial report of Santen Pharmaceutical Co., Ltd. is 31/03/2021. Gross profit Santen Pharmaceutical Co., Ltd. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Santen Pharmaceutical Co., Ltd. is 45 495 000 000 $
Cost of revenue Santen Pharmaceutical Co., Ltd. is the total cost of producing and distributing of products and services of a company. Cost of revenue Santen Pharmaceutical Co., Ltd. is 22 324 000 000 $ Total revenue Santen Pharmaceutical Co., Ltd. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Santen Pharmaceutical Co., Ltd. is 67 819 000 000 $ Operating income Santen Pharmaceutical Co., Ltd. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Santen Pharmaceutical Co., Ltd. is 26 240 000 000 $
Net income Santen Pharmaceutical Co., Ltd. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Santen Pharmaceutical Co., Ltd. is -14 287 000 000 $ Current assets Santen Pharmaceutical Co., Ltd. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Santen Pharmaceutical Co., Ltd. is 206 231 000 000 $ Total assets Santen Pharmaceutical Co., Ltd. refers to the total amount of assets owned by a person or entity. Total assets Santen Pharmaceutical Co., Ltd. is 402 353 000 000 $
31/03/2021
31/12/2020
30/09/2020
30/06/2020
31/03/2019
31/12/2018
30/09/2018
30/06/2018
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
45 495 000 000 $
36 689 000 000 $
36 378 000 000 $
32 822 000 000 $
39 866 000 000 $
34 824 000 000 $
35 111 000 000 $
33 461 000 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
22 324 000 000 $
26 192 000 000 $
24 964 000 000 $
24 741 000 000 $
20 950 000 000 $
24 042 000 000 $
22 750 000 000 $
23 022 000 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
67 819 000 000 $
62 881 000 000 $
61 342 000 000 $
57 563 000 000 $
60 816 000 000 $
58 866 000 000 $
57 861 000 000 $
56 483 000 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
-
-
-
-
-
-
-
-
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
26 240 000 000 $
8 581 000 000 $
10 671 000 000 $
8 016 000 000 $
11 442 000 000 $
12 832 000 000 $
10 809 000 000 $
10 015 000 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-14 287 000 000 $
7 304 000 000 $
7 624 000 000 $
6 189 000 000 $
8 578 000 000 $
8 995 000 000 $
7 526 000 000 $
6 854 000 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
-17 653 000 000 $
6 530 000 000 $
5 507 000 000 $
5 616 000 000 $
6 668 000 000 $
6 128 000 000 $
5 345 000 000 $
5 619 000 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
41 579 000 000 $
54 300 000 000 $
50 671 000 000 $
49 547 000 000 $
49 374 000 000 $
46 034 000 000 $
47 052 000 000 $
46 468 000 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
206 231 000 000 $
183 892 000 000 $
187 083 000 000 $
209 053 000 000 $
194 742 000 000 $
188 851 000 000 $
186 941 000 000 $
174 440 000 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
402 353 000 000 $
413 087 000 000 $
420 021 000 000 $
409 586 000 000 $
391 186 000 000 $
388 284 000 000 $
400 030 000 000 $
378 420 000 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
62 888 000 000 $
52 913 000 000 $
58 745 000 000 $
82 346 000 000 $
70 796 000 000 $
75 394 000 000 $
75 237 000 000 $
57 483 000 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
-
-
-
-
60 663 000 000 $
48 679 000 000 $
51 785 000 000 $
48 650 000 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
-
-
-
-
-
-
-
-
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
-
-
-
-
98 614 000 000 $
89 515 000 000 $
95 433 000 000 $
89 133 000 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
-
-
-
-
25.21 %
23.05 %
23.86 %
23.55 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
307 585 000 000 $
315 221 000 000 $
316 061 000 000 $
306 193 000 000 $
290 900 000 000 $
297 122 000 000 $
302 914 000 000 $
287 580 000 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
-
-
-
-
10 200 000 000 $
5 445 000 000 $
20 456 000 000 $
-3 207 000 000 $
Last revenue report of Santen Pharmaceutical Co., Ltd. was 31/03/2021. According to last financial report total revenue in Santen Pharmaceutical Co., Ltd. was 67 819 000 000 US dollar and changed by +11.52% since last year. Net income in Santen Pharmaceutical Co., Ltd. was -14 287 000 000 $ in last quartal, net income changes to -266.554%.
Current cash Santen Pharmaceutical Co., Ltd. - the sum of all of the cash a company has on the date of report. Current cash Santen Pharmaceutical Co., Ltd. is 62 888 000 000 $
